Key result
Untreated growth hormone deficiency is linked to a ~52% higher small HDL particle percentage.
Why the study?
Dyslipidemia contributes to increased mortality in adult growth hormone deficiency, but lipoprotein subfractions and their relationship with IGF-1 have not been explored.
Does growth hormone deficiency and its replacement alter lipoprotein subfractions in adults?
Cross-Sectional (n=57)
No
Does growth hormone deficiency and its replacement alter lipoprotein subfractions in adults?
Absolute Event Rate: 34.88% vs 22.94%
p-value: p=<0.001
Adult growth hormone deficiency is associated with pro-atherogenic alterations in lipoprotein subfractions despite normal standard lipid profiles, which may contribute to increased cardiovascular risk.
May indicate heightened CV risk in untreated GHD; leaves open whether GH replacement modifies HDL subfractions or outcomes.
Introduction Dyslipidemia is a common complication of adult growth hormone deficiency (AGHD) and considered an important contributor to increased mortality. Previous studies mainly focused on quantitative assessment of lipoproteins, but lipoprotein subfractions and their relationship with insulin-like growth factor 1 (IGF-1) have not been explored. Purpose To perform a comprehensive evaluation of lipoprotein subfractions and measuring apolipoprotein L1 (apoL1), sphingosine 1-phosphate (S1P) and apolipoprotein M (apoM) in AGHD. Materials and methods 11 GH-substituted (GHS) patients, 9 GH-unsubstituted (GHU) patients and 37 controls were included in the study. Lipoprotein subfractions were separated by the Lipoprint system. ApoL1, apoM and S1P were determined by ELISA. In the GHS patients GH-replacement was discontinued for 2 months. Measurements were performed before GH-discontinuation, at the end of the 2-month GH-withdrawal, and 1 month after reinstituting GH-replacement. Results Standard lipid parameters, apoM and apoL levels were not different between the groups. GHU patients demonstrated lower apolipoprotein A1 compared to controls (p=0.02) and higher apolipoprotein B100 compared to GHS (p=0.02). GHU and GHS showed higher S1P levels compared to controls (p=0.04 and p=0.01, respectively). Both GHU and GHS patients also presented higher percentage of intermediate-density lipoprotein (IDL) compared to controls (p=0.03 and p=0.01, respectively). Mean LDL size was lower in GHU compared to GHS (p=0.04). Percentage of intermediate HDL was lower in GHU and GHS compared to controls (p<0.001 and p<0.01, respectively). GHU demonstrated higher percentage of small HDL than controls (p<0.001). Overall, log 10 IGF-1 correlated positively with the percentage of large HDL (r=0.27; p=0.04) and intermediate HDL (r=0.38; p<0.01) and negatively with the percentage of small HDL (r=-0.46; p<0.01). Log 10 IGF-1 was the best predictor of small HDL (standardized β=-0.46; p<0.001) in overall subjects. In the GH-withdrawal study, the amount of HDL-6 increased with GH-withdrawal (p=0.03) and the percentage of IDL increased with reinstitution (p=0.05). Conclusion Despite no changes in standard lipid parameters, considerable alterations of lipoprotein subfractions were revealed in GH-deficient adults indicating that lipoprotein subfraction analysis may allow for a more precise cardiovascular risk assessment in AGHD. Associations between HDL subfractions and Log 10 IGF-1 demonstrate a novel insight into the role of GH in lipid metabolism.
No takes yet. Share an insight, caveat, or question.
Ratku et al. (2025) conducted a cross-sectional in Adult growth hormone deficiency (AGHD) (n=57). Untreated growth hormone deficiency vs. Healthy controls was evaluated on Percentage of small HDL (p=<0.001). Adults with untreated growth hormone deficiency demonstrated a significantly higher percentage of small HDL particles compared to healthy controls, indicating an unfavorable cardiovascular risk profile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: